Vitalhub (TSE:VHI) Price Target Lowered to C$12.00 at Scotiabank

Vitalhub (TSE:VHI) had its price objective dropped by equities researchers at Scotiabank from C$15.00 to C$12.00 in a research report issued to clients and investors on Wednesday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Scotiabank’s target price would indicate a potential upside of 40.85% from the company’s previous close.

Several other analysts also recently weighed in on VHI. Stifel Nicolaus set a C$15.00 target price on Vitalhub and gave the company a “buy” rating in a research note on Wednesday, October 15th. Royal Bank Of Canada lowered their target price on shares of Vitalhub from C$13.00 to C$12.00 and set an “outperform” rating on the stock in a research note on Monday, January 26th. Two investment analysts have rated the stock with a Strong Buy rating and five have issued a Buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of C$14.33.

Vitalhub Stock Performance

Shares of Vitalhub stock traded up C$0.27 during midday trading on Wednesday, reaching C$8.52. 1,165,726 shares of the company’s stock traded hands, compared to its average volume of 398,501. Vitalhub has a 52 week low of C$7.92 and a 52 week high of C$14.64. The company’s 50 day simple moving average is C$9.01 and its 200 day simple moving average is C$10.62. The company has a market cap of C$535.31 million, a price-to-earnings ratio of 213.00, a price-to-earnings-growth ratio of 1.18 and a beta of 0.83.

Vitalhub (TSE:VHI) last posted its earnings results on Thursday, November 6th. The company reported C($0.01) earnings per share for the quarter. Vitalhub had a return on equity of 3.01% and a net margin of 5.11%.The company had revenue of C$32.04 million during the quarter. As a group, equities research analysts predict that Vitalhub will post 0.2296467 earnings per share for the current year.

Insider Activity

In related news, Director Francis Nelson Shen acquired 148,700 shares of the company’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was purchased at an average price of C$9.05 per share, for a total transaction of C$1,345,735.00. Following the transaction, the director directly owned 148,700 shares of the company’s stock, valued at approximately C$1,345,735. This trade represents a ∞ increase in their position. Also, Director Anthony Pius Shen bought 5,470 shares of the company’s stock in a transaction dated Tuesday, December 23rd. The shares were purchased at an average price of C$9.23 per share, with a total value of C$50,488.10. Following the transaction, the director owned 5,470 shares of the company’s stock, valued at C$50,488.10. The trade was a ∞ increase in their ownership of the stock. 18.57% of the stock is owned by corporate insiders.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.